| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 405,607,000 | 378,799,000 | 348,650,000 | | Cost of Revenue | 306,158,000 | 286,515,000 | 264,152,000 | | | Gross Profit | 99,449,000 | 92,284,000 | 84,498,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 76,651,000 | 70,288,000 | 64,001,000 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 22,798,000 | 21,996,000 | 20,497,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 284,000 | 305,000 | 280,000 | | Earnings Before Interest And Taxes | 23,082,000 | 22,301,000 | 20,777,000 | | Interest Expense | 2,184,000 | 2,103,000 | 1,809,000 | | Income Before Tax | 20,898,000 | 20,198,000 | 18,968,000 | | Income Tax Expense | 7,145,000 | 6,908,000 | 6,365,000 | | Minority Interest | (499,000) | (406,000) | (425,000) | | | | Net Income From Continuing Ops | 13,254,000 | 12,884,000 | 12,178,000 | | | Non-recurring Events | | Discontinued Operations | 146,000 | (153,000) | (894,000) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 13,400,000 | 12,731,000 | 11,284,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,400,000 | $12,731,000 | $11,284,000 |
|
1.63% Nasdaq 
Income Statement
